Cost-effectiveness of screening for colorectal cancer with once-only flexible sigmoidoscopy and faecal occult blood test

Eline Aas ()

No 2008:6, HERO On line Working Paper Series from Oslo University, Health Economics Research Programme

Abstract: On the basis of a randomized controlled trial we estimate the cost per life-year gained for six different strategies for colorectal cancer screening. Individuals in the age group 50 to 64 years were randomly selected for either flexible sigmoidoscopy or a combination of flexible sigmoidoscopy and a faecal occult blood test. A comprehensive dataset was collected from the trial to estimate costs and gained life-years. There are some indications that screening for colorectal cancer can be cost-effective, but the results are not statistically significant after this short follow-up period.

Keywords: Keywords – screening; cost-effectiveness analysis; colorectal cancer; multinomial logit; probabilistic sensitivity analysis (search for similar items in EconPapers)
JEL-codes: C41 C52 I10 I18 (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-hea
Date: 2009-06-02

Downloads: (external link)
http://www.hero.uio.no/publicat/2008/2008_6.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:hhs:oslohe:2008_006

Access Statistics for this paper

More papers in HERO On line Working Paper Series from Oslo University, Health Economics Research Programme
Address: HERO / Institute of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway
Contact information at EDIRC.
Series data maintained by Gunn Kristin Tjoflot ().